Academic Entrepreneur of the Year 2014
Robert Woods, professor of biochemistry and molecular biology, and chemistry, and researcher in the Complex Carbohydrate Research Center, is a leading expert in the fields of glycomics and computational chemistry. He has worked as consultant for numerous companies interested in carbohydrate-based therapeutics, but he is also co-founder and president of his own early-stage biotechnology company, Glycosensors & Diagnostics. The company began formal operations in 2009 when it received its first NIH Phase I award. G&D is the developer of the patent-pending Lectenz biotechnology, which has applications in disease biomarker detection and in the production and development of therapeutic antibodies and other biologics. In 2013, G&D was awarded an NIH Phase II contract from the National Cancer Institute to further develop Lectenz. Their company is on the forefront of a rapidly growing area in the global pharmaceutical sector dedicated to the development of therapeutic biologics.